Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyethyl starch coload for postspinal anesthesia hypotension in C-section
NCT05475886Recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Feb 2024
- Primary completion
- Apr 2024
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of hetastarch in hypotension, sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Median Effective Dose and 90% Effective Dose. Started Feb 2024; status: recruiting.
02
Drugs
hetastarch
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05475886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05475886.